iBio
IBIO
#9760
Rank
NZ$86.07 M
Marketcap
NZ$3.83
Share price
9.57%
Change (1 day)
-31.89%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2025 (TTM): NZ-$2.63

According to iBio's latest financial reports the company's current EPS (TTM) is NZ-$2.56. an increase over its 2024 EPS that were of NZ-$10.82.

EPS history for iBio from 2007 to 2025

Annual EPS

Year EPS Change
2025NZ-$2.91-73.08%
2024NZ-$10.82-93.88%
2023NZ-$176.72-8.14%
2022NZ-$192.3892.67%
2021NZ-$99.85-80.33%
2020NZ-$507.58-35.11%
2019NZ-$782.17-38.96%
2018NZ-$1,281-6.1%
2017NZ-$1,36536.67%
2016NZ-$998.5233.33%
2015NZ-$748.8950%
2014NZ-$499.26-53.85%
2013NZ-$1,082-7.14%
2012NZ-$1,165-64.1%
2011NZ-$3,24577.27%
2010NZ-$1,831144.44%
2009NZ-$748.8912.93%
2008NZ-$663.1612.2%
2007NZ-$591.05

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$17.37-777.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
NZ-$0.87-66.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ-$13.26 417.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.35-191.56%๐Ÿ‡บ๐Ÿ‡ธ USA